As previously mentioned, DHX9 mediates EGFR binding to target gene promoters, including the CCND1 proto-oncogene that stimulates cyclin D1 transcriptional activation (Figure 3A), as observed in human breast cancer cells [38,70]. Here, DHX9 is linked to breast carcinoma.